#KidneyWk on X 13 hours ago

RT @RClaure_nefro: AKI-D pearls: •Gentle UF & individualized Rx-minimize dialytrauma •⬇️frequency/intensity as recovery starts •Prevent IDH…

View Post

#KidneyWk on X 13 hours ago

RT @edgarvlermamd: Concomitant Sparsentan and Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Adults With 🔬 IgA Nephropathy (IgAN) in…

View Post

#KidneyWk on X 13 hours ago

RT @abdelhamed012: CKM #KidneyWk https://t.co/7ndatNkWYs

View Post

#KidneyWk on X 13 hours ago

RT @RClaure_nefro: Post-AKI meds: • Dose smart: residual+dialysis CL, use TDM; PK/PD—vanc AUC/MIC>400; AG Cmax≈10×MIC; β-lactams time>MIC.…

View Post

#KidneyWk on X 13 hours ago

RT @Nefrontera: Fantastic talk by Dr Volker Vallon about the mechanisms of organ protection with SGLT2i beyond SGLT2 transporter #KidneyWk…

View Post

#KidneyWk on X 13 hours ago

RT @JAMA_current: Meta-analysis: #SGLT2 inhibitors slow kidney decline consistently across CKD severity and albuminuria range, supporting t…

View Post

#KidneyWk on X 13 hours ago

RT @IzabelaZakrocka: Happening now ⏰@SabineKaram6 @onconephsociety extensive review on paraneoplastic glomerular diseases @asnpublications…

View Post

#KidneyWk on X 13 hours ago

RT @ASNKidney: #KidneyWk 2025 comes to a close in Houston. Thank you for being part of the world's premier nephrology meeting. 📅 Mark your…

View Post

#KidneyWk on X 13 hours ago

RT @abedborghol: Wonderful time this year at ASN #KidneyWk reconnecting with friends and mentors. See you next year in Denver! 🫘 @CCF_IMCH…

View Post

#KidneyWk on X 13 hours ago

@docmoe82 @kidney_boy @brendonneuen "Who and how to give an SGLT2i to a type 1 DM patient #KidneyWk"? Seems like you are playing with 🔥.

View Post